Related Experiment Video
Updated: Apr 12, 2026
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
The diagnosis and treatment of dermatitis herpetiformis
Emiliano Antiga1, Marzia Caproni1
1Department of Surgery and Translational Medicine, Section of Dermatology, University of Florence, Florence, Italy.
Insights
Dermatitis herpetiformis (DH) is a chronic skin disease linked to celiac disease. Diagnosis involves skin biopsy and antibody tests, with treatment focusing on a gluten-free diet and medication.
Area of Science:
- Dermatology
- Gastroenterology
- Immunology
Background:
- Dermatitis herpetiformis (DH) is an inflammatory skin condition with a chronic, relapsing course.
- DH is recognized as the specific cutaneous manifestation of celiac disease.
- Recent guidelines suggest duodenal biopsy is unnecessary for diagnosing DH in celiac patients.
Purpose of the Study:
- To review and discuss the latest data on the diagnosis and management of Dermatitis herpetiformis.
- To highlight diagnostic criteria and therapeutic strategies for DH.
Main Methods:
- Review of recent literature on DH diagnosis and management.
- Discussion of diagnostic markers including direct immunofluorescence (DIF) and anti-tissue transglutaminase (tTG) antibody testing.
- Exploration of therapeutic approaches involving gluten-free diet and pharmacotherapy.
Main Results:
- Diagnosis of DH is supported by clinical, histopathological, and immunopathological findings, specifically granular IgA deposits via DIF and positive anti-tTG antibodies.
- A gluten-free diet is the primary treatment, often supplemented with medications like dapsone to manage acute symptoms.
- The review synthesizes current evidence on effective diagnostic and management strategies.
Conclusions:
- DH diagnosis can be established through specific immunopathological findings and serological markers, potentially obviating the need for duodenal biopsy in some cases.
- Effective management involves a strict gluten-free diet combined with symptomatic treatment.
- DH significantly impacts patients' overall health and quality of life, underscoring the importance of timely diagnosis and comprehensive care.
Abstract:
Dermatitis herpetiformis (DH) is an inflammatory cutaneous disease with a chronic relapsing course, pruritic polymorphic lesions, and typical histopathological and immunopathological findings. According to several evidences, DH is considered the specific cutaneous manifestation of celiac disease, and the most recent guidelines of celiac disease have stated that, in celiac patients with a proven DH, a duodenal biopsy is unnecessary for the diagnosis. In this review, the most recent data about the diagnosis and the management of DH have been reported and discussed. In particular, in patients with clinical and/or histopathological findings suggestive for DH, the finding of granular IgA deposits along the dermal-epidermal junction or at the papillary tips by direct immunofluorescence (DIF) assay, together with positive results for anti-tissue transglutaminase antibody testing, allows the diagnosis. Thereafter, a gluten-free diet should be started in association with drugs, such as dapsone, that are able to control the skin manifestations during the first phases of the diet. In conclusion, although DH is a rare autoimmune disease with specific immunopathological alterations at the skin level, its importance goes beyond the skin itself and may have a big impact on the general health status and the quality of life of the patients.
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
01:26Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
01:29Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents